This Solicitation opportunity from Department Of Defense was posted on May 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
LEVONORGESTREL AND
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract specifies the procurement of Levonorgestrel and Ethinyl Estradiol Tablets, USP, manufactured by Teva Pharmaceuticals USA, Inc., with National Drug Code (NDC) 00555-9047-58, in a total quantity of six packages, each containing 168 tablets organized into six 28-tablet cycles. Each cycle consists of six tablets with 0.050 mg levonorgestrel and 0.030 mg ethinyl estradiol, followed by five tablets with 0.075 mg levonorgestrel and 0.040 mg ethinyl estradiol, ten tablets with 0.125 mg levonorgestrel and 0.030 mg ethinyl estradiol, and seven inert tablets, making up a full hormonal contraceptive regimen. The unit of issue is a package (PG), and the total shelf life must be 24 months with a minimum of 21 months remaining at the time of receipt by the first government activity. The product must be stored at controlled room temperature (20°–25°C or 68°–77°F) in accordance with USP standards. Packaging and labeling must strictly conform to Medical Marking Standard No. 1, which replaces MIL-STD-129 for all medical acquisitions, and packaging must meet MIL-STD-2073-1E requirements to ensure protection from damage during transport. The item is regulated by the FDA and requires verification through EBS referral prior to award. The solicitation number is SPE2DP-26-T-3333, with a response deadline of May 18, 2026, and delivery is required within 20 days of order placement, FOB destination, with inspection and acceptance also occurring at the destination. The contract incorporates a full suite of Federal Acquisition Regulation (FAR) and Defense Federal Acquisition Regulation Supplement (DFARS) clauses, including requirements for safeguarding covered defense information, combating trafficking in persons, employment eligibility verification, sustainable procurement, hazardous materials labeling, and cybersecurity compliance in line with NIST SP 800-171. All contractors must hold current SAM.gov registration and comply with the Buy American Act and Berry Amendment. The contracting activity is under the Department of Defense’s Medical Supply Chain Pharm FSA, and all proposals must be submitted electronically via the D
General Info
Agency
Contract Value
$399.18NAICS
Place of Performance
USASet-Aside
Awardee
Award Issued Date
Timeline
Submission Closed
Organization & Contact Information
Full Description
LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
RX ONLY
.
CONSISTS OF 6 CYCLES TOTAL WITH 28 TABLETS PER CYCLE COMPACT CONTAINING
IN SEQUENCE:
6 TABLETS LEVONORGESTREL 0.050 MG (50 MCG) AND ETHINYL ESTRADIOL 0.030
MG (30 MCG) FOLLOWED BY
5 TABLETS LEVONORGESTREL 0.075 MG (75 MCG) AND ETHINYL ESTRADIOL 0.040
MG (40 MCG) FOLLOWED BY
10 TABLETS LEVONORGESTREL 0.125 MG (125 MCG) AND ETHINYL ESTRADIOL 0.030
MG (30 MCG) FOLLOWED BY
7 TABLETS OF INERT INGREDIENTS
.
UNIT OF ISSUE IS A PACKAGE CONTAINING 168 EACH. (6 CYCLES OF 28 TABLETS
EACH).
.
TOTAL SHELF LIFE IS 24 MONTHS.
.
THERE SHALL BE A MINIMUM OF 21 MONTHS OF REMAINING SHELF LIFE
AT THE TIME OF RECEIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
STORE AT 20° 25°C (68 ° 77°F). [SEE USP CONTROLLED ROOM
TEMPERATURE.]
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
3/8/2016
.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 168 EA 1 PG = 168 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
SPE2DP-26-T-3333
SECTION B
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-9047-58
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016705555 0001 PG 6.000
NSN/MATERIAL:6505012240176
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-224-0176 Quantity: 6 PG Purchase Request: 7016705555QTY: 6 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS